Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Method for Selectively Inhibiting Reuptake of Serotonin and Norepinephrine Using Yeast Extract
Korea Health Industry Development Institute (KHIDI) South Korea flag South Korea
Abstract ID:
The eventual end commercialization of our technologies are on the role of our alliances. We continuously develop our internal strengths and capabilities while reaching out to wide and solid international partnerships and collaborations....
Contact Yong U Kim
Participants
You
Email me a copy of this message
MECHANISM OF ACTION
Novel use of yeast extract as SSRIs, Application for Diseases, Market Opportunity

Yeast, generally recognized as safe (GRAS) for the human body, contains 50% or more quality proteins, excess minerals, vitamin B, etc., so it has been widely used in the liquor or bakery industry as a source of protein, nucleic acids, enzymes, liquids, vitamins, minerals, etc..  Yeast extracts produced by autolytic enzyme or other proteases have been used as a source of microorganism fermentation media, seasonings, and health foods. 


A yeast extract or yeast-derived bioactive peptide having an activity of selectively inhibiting reuptake of serotonin and norepinephrine , which can be effectively used in preventing or treating various diseases related to reuptake of serotonin and norepinephrine, especially depression, anxiety, stress, fatigue and obesity.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

FEATURED
Last Updated Jun 2016
Technology Type THERAPEUTIC
Phase of Development EARLY STAGE
GOVERNMENT INSTITUTE